Skip to main content
Caplight Logo









Mantis Biotechnology

Mantis Biotechnology

Private
New York City, New YorkHealthcare & Life Scienceshttps://mantisbiotech.com/

Last Round

Seed

Mar 29, 2026

Total Funding Raised

$13.7M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Mantis Biotechnology is a biotechnology and artificial intelligence company that provides a foundational infrastructure layer for building human-in-computer models by unifying fragmented data sources to create validated digital twins.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Synthetic Data, Medical Devices, Medical AI, Clinical Trials

Business Model

B2B

Customer Profile

Subscription SaaS, Services & Consulting

AI Layer

Infrastructure

Keywords

digital twinsynthetic databiomedical simulationphysics-based modelingmedical device testingpredictive modelingin silico trialsclinical trial simulationFDA submissionbiotech infrastructureAI for healthcarehuman physiology modelingdigital healthmedtechAI agent security

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Mantis Biotechnology Comparables

Compare Mantis Biotechnology with similar companies based on industry and business-model similarity.

Mantis Biotechnology comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Virtonomy.io
80%
AIBODY
78%
InSilicoTrials Technologies
73%

Mantis Biotechnology Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedMar 29, 2026
SeedJan 30, 2026

Key People

Founding team and executive leadership

Georgia Witchel

Chief Executive Officer

Executive Team

Mantis Biotechnology Investors

Notable investors and investment history

Mantis Biotechnology investors
InvestorRounds
DecibelSeed
Pioneer FundSeed
FenwickSeed
Y CombinatorSeed
Liquid 2 VenturesSeed
StoryHouse VenturesSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 29, 2026

    $7.4M round led by Decibel

  • Jan 30, 2026

    $6.3M round led by Decibel.

Mantis Biotechnology Filings

Explore SEC and related filing metadata, where available.

Mantis Biotechnology filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Mantis Biotechnology's valuation, stock price, and market status.

Is Mantis Biotechnology a public or private company?

Mantis Biotechnology is a private company.

What is the current stock price of Mantis Biotechnology?

Mantis Biotechnology is a private company with no public stock price. No recent secondary market data is available.

How much is Mantis Biotechnology worth (valuation)?

Valuation information for Mantis Biotechnology is not publicly available.

Can I buy Mantis Biotechnology stock?

Mantis Biotechnology shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Mantis Biotechnology's last funding round?

Mantis Biotechnology's most recent funding round was Seed on January 29, 2026.

Who are the main investors in Mantis Biotechnology?

Key investors in Mantis Biotechnology include Decibel.

Will Mantis Biotechnology IPO soon?

No public IPO plans have been announced for Mantis Biotechnology.

How can I track Mantis Biotechnology secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Mantis Biotechnology's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersNew York City, New York
Employee Range6
Year Founded2025
Last FundingMar 29, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?